19-32676309-AC-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_207391.3(RGS9BP):c.47delC(p.Thr16fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,607,992 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
RGS9BP
NM_207391.3 frameshift
NM_207391.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.22
Genes affected
RGS9BP (HGNC:30304): (regulator of G protein signaling 9 binding protein) The protein encoded by this gene functions as a regulator of G protein-coupled receptor signaling in phototransduction. Studies in bovine and mouse show that this gene is expressed only in the retina, and is localized in the rod outer segment membranes. This protein is associated with a heterotetrameric complex, specifically interacting with the regulator of G-protein signaling 9, and appears to function as the membrane anchor for the other largely soluble interacting partners. Mutations in this gene are associated with prolonged electroretinal response suppression (PERRS), also known as bradyopsia. [provided by RefSeq, Mar 2010]
ANKRD27 (HGNC:25310): (ankyrin repeat domain 27) Enables guanyl-nucleotide exchange factor activity and small GTPase binding activity. Involved in endocytic recycling and negative regulation of SNARE complex assembly. Acts upstream of or within early endosome to late endosome transport. Located in endosome; lysosome; and plasma membrane. Implicated in eosinophilic esophagitis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.934 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS9BP | NM_207391.3 | c.47delC | p.Thr16fs | frameshift_variant | 1/1 | ENST00000334176.4 | NP_997274.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS9BP | ENST00000334176.4 | c.47delC | p.Thr16fs | frameshift_variant | 1/1 | 6 | NM_207391.3 | ENSP00000334134.3 | ||
ANKRD27 | ENST00000590519.2 | c.-555delG | 5_prime_UTR_variant | 1/4 | 5 | ENSP00000464819.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152120Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
23
AN:
152120
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000743 AC: 18AN: 242190Hom.: 0 AF XY: 0.0000528 AC XY: 7AN XY: 132550
GnomAD3 exomes
AF:
AC:
18
AN:
242190
Hom.:
AF XY:
AC XY:
7
AN XY:
132550
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000108 AC: 157AN: 1455872Hom.: 0 Cov.: 30 AF XY: 0.000101 AC XY: 73AN XY: 723596
GnomAD4 exome
AF:
AC:
157
AN:
1455872
Hom.:
Cov.:
30
AF XY:
AC XY:
73
AN XY:
723596
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152120Hom.: 0 Cov.: 34 AF XY: 0.000175 AC XY: 13AN XY: 74316
GnomAD4 genome
AF:
AC:
23
AN:
152120
Hom.:
Cov.:
34
AF XY:
AC XY:
13
AN XY:
74316
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This sequence change creates a premature translational stop signal (p.Thr16Argfs*10) in the RGS9BP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 220 amino acid(s) of the RGS9BP protein. This variant is present in population databases (rs765574929, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RGS9BP-related conditions. ClinVar contains an entry for this variant (Variation ID: 947230). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at